Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Harm Reduct J[TA])
603 results
  • Smokeless tobacco mortality risks: an analysis of two contemporary nationally representative longitudinal mortality studies. [Journal Article]
  • HRHarm Reduct J 2019 Apr 11; 16(1):27
  • Fisher MT, Tan-Torres SM, … Sarkar MA
  • CONCLUSIONS: Emerging epidemiological data provides a new perspective on the health risks of SLT use compared to risks associated with cigarette smoking. HR estimates derived from two current US datasets, which include data on contemporary tobacco products, demonstrate a clear mortality risk differential between modern SLT products and cigarettes. Cigarette smokers had an increased overall mortality risk and risk for several disease-specific causes of death, while SLT users consistently had lower mortality risks.
  • Barriers to using new needles encountered by rural Appalachian people who inject drugs: implications for needle exchange. [Journal Article]
  • HRHarm Reduct J 2019 Apr 02; 16(1):23
  • Davis SM, Kristjansson AL, … Fisher M
  • CONCLUSIONS: Congruent with previous findings from urban locations, in rural West Virginia, the ability of PWID to use a new needle obtained from a needle exchange for every injection may be compromised by fear of arrest. In addition, pharmacy sales of new needles to PWID may be blunted by an absence of explicit laws mandating nonprescription sales. Future studies should explore interventions that align the public health goals of NEPs with the occupational safety of law enforcement and health outreach goals of pharmacists.
  • Hepatitis C services at harm reduction centres in the European Union: a 28-country survey. [Journal Article]
  • HRHarm Reduct J 2019 Mar 21; 16(1):20
  • Pericàs JM, Bromberg DJ, … Lazarus JV
  • CONCLUSIONS: Not all EU member states have harm reduction services that provide HCV tests, and many do not have established referral systems with treatment providers. Moreover, the inability of addiction specialists to prescribe HCV treatment points to missed opportunities to make treatment more accessible. Further, discrepancies were noted between the available HCV services and stakeholders' knowledge about their availability.
New Search Next